MCP · for MSLs and field medical teams
Walk into a scientific exchange knowing what the clinician has already said in public.
Public commentary shows what a clinician is curious or skeptical about before the meeting, not after.
When you need it
- A scheduled scientific exchange or MSL visit
- A new key opinion leader in the territory
- A clinician who just spoke at a congress or on a podcast
Ask your agent
“I'm meeting five oncologists next week. For each, summarize what they have said publicly about NEONIPIGA and neoadjuvant immunotherapy in the last 12 months, with sources.”
More to ask
- “Has Dr. <name> changed their view on organ preservation since last year? Show the posts or episodes where it shows.”
- “Which questions about MSI/MMR testing timing do clinicians raise in public?”
- “Give me three open questions from the NEONIPIGA report that would make a good scientific exchange with a surgical oncologist.”
Before and after
How the work changes
Today
- Scroll a clinician's X feed and hope the relevant post is recent
- Skip the hour-long podcast where they explained their reasoning
- Rely on a colleague's memory of the last advisory board
With Erudio
- One question to your agent covers posts, podcasts and video
- Each statement links to the exact passage and date
- A profile for each clinician: NPI specialty and practice, research IDs and the podcasts and videos they appear in, each field with its source
- Report findings give the wider conversation around the same trial
What you get
- What each clinician has said in public about your trials and drugs, with dates and links
- The questions they have raised, kept separate from what the evidence shows
- Relevant report findings to bring into the conversation
Tools it calls
mcp
lookup_profile({ "npis": ["<NPI>", "<NPI>", "<NPI>"] })
search({ "query": "<trial or drug>", "author": "<X username>", "published_after": "<date>" })
search_reports({ "drug": "<drug>" })
read_report({ "report_id": "<id>", "sections": ["findings"] })In a published report
NEONIPIGA
NCT04006262
Questions a gastrointestinal oncologist may bring to a meeting about NEONIPIGA, taken from the published report's findings.
- F1Organ preservation is compelling for selected responders, but clinical response does not settle the need for surgery
- F2Immunotherapy incorporation attracts support; chemotherapy omission and the preferred combination remain contested
- F6Early tumor-specific testing and confirmation—not presumed MSI or a single positive biopsy—shape treatment choices
What it does not do
- Public commentary only: no private notes, CRM data or call recordings.
- A view is attributed to a clinician only when the source supports it; otherwise it stays unattributed.
- It prepares a scientific exchange. It is not a promotional call plan.